COMMUNIQUÉS West-GlobeNewswire

Clearmind Successfully Completes Patient Recruitment for the First Alcohol Use Disorder Cohort of its CMND-100 Phase I/IIa Clinical Trial
27/10/2026
Milestone advances Clearmind’s clinical program as the company continues to develop CMND‑100 as a potential novel therapeutic candidate for alcohol use disorder Vancouver, Canada, Oct. 27, 2026 (GLOBE NEWSWIRE) -- [...]
Microbot Medical® Secures its First Office-Based Lab (OBL) Customer for the LIBERTY® Endovascular Robotic System
27/10/2026
ELMNT IR also became the first account on the West Coast, marking a geographic expansion which aligns with the Company’s Full Market Release strategy. The Company believes the OBLs represent a rapidly growing healthcare [...]
Onconetix Acquisition Target Realbotix Launches Echo Humanoid Robot Line with Tabletop and Full Body Models Designed for Education, Wellness, and Social Engagement
27/10/2026
Echo Tabletop Priced at $11,950 and Echo Full Body at $59,950; First Production Run of 250 Units Available for 2027 Delivery; Onconetix Recently Entered into a Definitive Agreement to Acquire Realbotix LLC, a Subsidiary [...]
NEXGEL Regains Compliance with Nasdaq Listing Requirement
27/10/2026
LANGHORNE, Pa., Oct. 27, 2026 (GLOBE NEWSWIRE) -- NEXGEL, Inc. (“NEXGEL” or the “Company”) (NASDAQ: NXGL), a company with a patient-centric medical technology sales and marketing team working closely with clinicians to [...]
Pyxis Oncology to Present Micvotabart Pelidotin (MICVO) Phase 1 Monotherapy Data in Late-Breaking Oral Presentation and Two Poster Presentations at EORTC-NCI-AACR Symposium on Molecular Targets and Cancer Therapeutics
27/10/2026
BOSTON, Oct. 27, 2026 (GLOBE NEWSWIRE) -- Pyxis Oncology, Inc. (Nasdaq: PYXS), a clinical-stage company developing next-generation therapeutics for difficult-to-treat cancers, today announced a late-breaking oral [...]
Vanquish Brands Announces 2026 Financial Results Estimated to Achieve a 152% 3-Year Annualized Revenue Growth Rate Driven by Its Flagship Brand Pistol and Paris
27/10/2026
Record Performance Results Driven by Increased Demand, Expansion of Nationwide Distribution, Product Innovation and Brand Recognition AGASSIZ, British Columbia, Oct. 27, 2026 (GLOBE NEWSWIRE) -- Vanquish Holdings Inc [...]
Syncromune Reports Long-Term Data from Phase 1 Study in Metastatic Prostate Cancer with Investigational SYNC-T Therapy SV-102
27/10/2026
Data support potential for highly differentiated clinical impact for patients suffering from metastatic prostate cancer 50% of patients who achieved a complete response (n=6) remain disease-free more than two years [...]
Nexalin Technology Announces Fourth Peer-Reviewed Publication in Alzheimer's Disease: 15 mA DIFS™ Significantly Improves Sleep Quality in Patients with Mild Alzheimer's Disease
27/10/2026
Results from the randomized, double-blind, sham-controlled TRANSFORM-AD study published in the Journal of Alzheimer's Disease, a recognized international peer-reviewed journal Statistically significant improvement in [...]
NorthStar Day Program, First of Its Kind in the Southeast, to Open in Palm Beach Gardens on November 4, 2026
27/10/2026
Innovative multidisciplinary program brings education, therapy, psychiatry and behavioral health services together under one roof for neurodivergent children ages 5–12 PALM BEACH GARDENS, Fla., Oct. 27, 2026 (GLOBE [...]
Pluri to Host Investor Conference Calls to Discuss Updates and Strategic Developments
27/10/2026
English-language call at 8:30 a.m. Eastern Time and Hebrew-language call at 11:00 a.m. Israel Time on Thursday, October 29, 2026 HAIFA, Israel, Oct. 27, 2026 (GLOBE NEWSWIRE) -- Pluri Inc. (Nasdaq and TASE: PLUR) (“ [...]
Exagen to Announce Third Quarter Financial Results on November 10, 2026
27/10/2026
CARLSBAD, Calif., Oct. 27, 2026 (GLOBE NEWSWIRE) -- Exagen Inc. (Nasdaq: XGN), a leading provider of innovative autoimmune testing, will release financial results for the quarter ended September 30, 2026, before the [...]
Emerging Digital Health Companies Choose HealthEx’s Platform and Health Records API to Personalize User Experiences with Clinical Context
27/10/2026
Companies in AI health coaching, rare disease care, caregiving, clinical trial matching and more build on the HealthEx health records API and MCP server to bring patients’ consented medical records from 90% of U.S. care [...]
aTyr Pharma Announces One-for-40 Reverse Stock Split
27/10/2026
aTyr’s common stock to begin trading on a post-split adjusted basis on October 29, 2026 SAN DIEGO, Oct. 27, 2026 (GLOBE NEWSWIRE) -- aTyr Pharma, Inc. (Nasdaq: ATYR) (“aTyr” or the “Company”), a clinical stage [...]
The Gene Lay Institute of Immunology and Inflammation Expands World-Class Research Leadership, Appointing Four New Members
27/10/2026
Drs. Marco Colonna, Francisco J. Quintana, Howard L. Weiner, and Jun R. Huh join to advance clinical discovery in cross-system immunology. BOSTON, Oct. 27, 2026 (GLOBE NEWSWIRE) -- The Gene Lay Institute of Immunology [...]
Egetis Therapeutics Announces U.S. Launch of EMCITATE® for Patients with MCT8 Deficiency
27/10/2026
EMCITATE is the first and only FDA-approved treatment for peripheral thyrotoxicosis in adults and pediatric patients with MCT8 deficiency in the United States Egetis RareLink™, the dedicated patient support program, [...]
Coherus to Participate in Upcoming Investor Conferences
27/10/2026
REDWOOD CITY, Calif., Oct. 27, 2026 (GLOBE NEWSWIRE) -- Coherus Oncology, Inc. (NASDAQ: CHRS), today announced that the company will be webcasting its participation in the following upcoming investor conferences: [...]
Oncolytics Biotech® Reports Strong Durability and Survival Data in Anal Cancer, Positioning Pelareorep as Potential Backbone Immunotherapy Across HPV-Driven Cancers
27/10/2026
GOBLET Cohort 4 demonstrates approximately 15-month median duration of response that exceeds historical results for approved second-line checkpoint inhibitor monotherapy 100% of responding patients survived for longer [...]
Acentra Health Names Mihriban Brickner as Senior Vice President of Operations
27/10/2026
Experienced healthcare operations leader will drive company's key Integrated Health Solutions initiatives and support clients MCLEAN, Va., Oct. 27, 2026 (GLOBE NEWSWIRE) -- Acentra Health , a technology and health [...]
Fort Collins Oral and Maxillofacial Surgeon Dr. Daetwyler Provides Free Dental Care in Cripple Creek
27/10/2026
FORT COLLINS, Colo. and CRIPPLE CREEK, Colo., Oct. 27, 2026 (GLOBE NEWSWIRE) -- U.S. Oral Surgery Management ( USOSM ) recognizes its surgeon partner Michael Daetwyler , DDS – as he completes medical mission work in [...]

Pages

Other news

Test 2

22/10/2026

Lorem ipsum

Test 1

22/10/2026

Lorem upsum